FDA Approves Erosive GERD Therapy Vonoprazan

Phathom Pharmaceuticals' vonoprazan (Voquenza) sets a new standard in erosive gastroesophageal reflux disease (GERD) therapy.

Related Keywords

United States ,Los Angeles ,Colinw Howden ,Terrie Curran ,Phathom Pharmaceuticals ,University Of Tennessee College Medicine ,Image Credit ,Tennessee College ,Erosive Esophagitis ,Gerd ,Fda Approval ,